TrianglePUBLICATIONS · 19720904
Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Oct 1
- First author
- Quintás-Cardama A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Quintás-Cardama A
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Manshouri T
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Ravandi F
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Ferrajoli A
- type
- Author
- name
- Bueso-Ramos C
- type
- Author
- name
- Verstovsek S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Quintás-Cardama A
- type
- Author
- name
- Kantarjian HM
- type
- Author
- name
- Manshouri T
- type
- Author
- name
- Thomas D
- type
- Author
- name
- Cortes J
- type
- Author
- name
- Ravandi F
- type
- Author
- name
- Garcia-Manero G
- type
- Author
- name
- Ferrajoli A
- type
- Author
- name
- Bueso-Ramos C
- type
- Author
- name
- Verstovsek S
- type
- Author
- bibliography ids
- nci-bib-2de5364ff4d3a85b5fa490cd
- book metadata
- content sha256
- d51965b75bd287098efb783f3a574a9fe574d3315e926e4ba3ac5db51f1d4b55
- document type
- citation
- dois
- 10.1200/JCO.2009.22.6548
- electronic publication date
- display
- 2009 Aug 31
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19720904
- immutable id
- pubmed:19720904@d51965b75bd287098efb783f3a574a9fe574d3315e926e4ba3ac5db51f1d4b55
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 4760-6
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19720904
- provenance
- batch id
- 0706b5111d1451f52f74
- provider
- NCBI PubMed ESummary
- record sha256
- 69d891d149f042b4af380a9293469d765903fb512dad446b030b1557fb8e2232
- response sha256
- 98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
- retrieved at
- 2026-09-09T23:46:29.215195+00:00
- publication date
- display
- 2009 Oct 1
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lenalidomide plus prednisone results in durable clinical, histopathologic, and molecular responses in patients with myelofibrosis.
Preserved source evidence · Not medical advice